FILTER
FILTERED INTERVIEW RESULTS
Shirley Qi
PRESIDENT, SOUTHEAST ASIA, AUSTRALIA & NEW ZEALAND (SEAANZ) & HEAD OF NUTRITION AND CARE DIVISION, APAC, EVONIK
Evonik explains its strong attraction for Singapore where its drive for innovation and sustainability fit well.
Martín Fueyo
DIRECTOR GENERAL, AGRICULTURA NACIONAL S.A. DE C.V. (DRAGÓN)
Agricultura Nacional is relying on its laboratory research and collaboration with its clients for growth in Mexico.
Roma Shah & Komal Doshi
CEO & DIRECTOR, EASTMEN CHEMICALS
Eastmen Chemicals is set on increasing its market beyond India.
Andreas Hauser
MANAGING DIRECTOR, TÜV SÜD ASIA PACIFIC
TÜV SÜD Asia Pacific speaks to GBR about industry transformation and what that entails.
Henri Nejade
COO, BRENNTAG SPECIALTIES
Brenntag explains its global transformation plan that has split the business into two divisons: Brenntag Specialities and Brenntag Essentials.
Francisco Rubio
PRESIDENT, KEMIKALS
Kemilkas is a Mexican distributor with a focus on innovation and environmental sustainability.
Allan Yong
SENIOR VICE PRESIDENT & MARKET HEAD, SOUTH EAST ASIA, ECOLAB
Ecolab is a global leader in water, hygiene and infection prevention solutions and services that protect people and vital resources.
Sean Spencer
VICE PRESIDENT AND MANAGING DIRECTOR, AFTON CHEMICAL ASIA
Afton Chemical Asia Pacific describes how its focus and products are adapting to the changing requirements of a global drive towards environmental sustainability.
Ziyang Fan
HEAD OF DIGITAL TRADE, WORLD ECONOMIC FORUM (WEF)
Singapore is a leader when it comes to digital trade and recent policy developments will open great opportunities, as well as paving the way for other countries to follow suit.
Thomas Holenia
PRESIDENT, HENKEL SINGAPORE
Henkel Singapore explains how it is adapting methods, products and marketing to prosper during a difficult year.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
